Cargando…

Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering

As genome engineering advances cell-based therapies, a versatile approach to introducing both CRISPR-Cas9 ribonucleoproteins (RNPs) and therapeutic transgenes into specific cells would be transformative. Autologous T cells expressing a chimeric antigen receptor (CAR) manufactured by viral transducti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamilton, Jennifer R., Tsuchida, Connor A., Nguyen, David N., Shy, Brian R., McGarrigle, E. Riley, Sandoval Espinoza, Cindy R., Carr, Daniel, Blaeschke, Franziska, Marson, Alexander, Doudna, Jennifer A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236216/ https://www.ncbi.nlm.nih.gov/pubmed/34077734 http://dx.doi.org/10.1016/j.celrep.2021.109207

Ejemplares similares

CRISPR–Cas9-mediated nuclear transport and genomic integration of nanostructured genes in human primary cells
por: Lin-Shiao, Enrique, et al.
Publicado: (2022)

Broad-spectrum CRISPR-Cas13a enables efficient phage genome editing
por: Adler, Benjamin A., et al.
Publicado: (2022)

Evolution of CRISPR RNA recognition and processing by Cas6 endonucleases
por: Niewoehner, Ole, et al.
Publicado: (2014)

Programmable RNA recognition and cleavage by CRISPR/Cas9
por: O’Connell, Mitchell R., et al.
Publicado: (2014)

Nucleosome breathing and remodeling constrain CRISPR-Cas9 function
por: Isaac, R Stefan, et al.
Publicado: (2016)

Conformational control of DNA target cleavage by CRISPR–Cas9
por: Sternberg, Samuel H., et al.
Publicado: (2015)

RNA-dependent RNA targeting by CRISPR-Cas9
por: Strutt, Steven C, et al.
Publicado: (2018)

DNA interrogation by the CRISPR RNA-guided endonuclease Cas9
por: Sternberg, Samuel H., et al.
Publicado: (2014)

Cas1–Cas2 complex formation mediates spacer acquisition during CRISPR–Cas adaptive immunity
por: Nuñez, James K., et al.
Publicado: (2014)

Integrase-mediated spacer acquisition during CRISPR–Cas adaptive immunity
por: Nuñez, James K., et al.
Publicado: (2015)

Foreign DNA capture during CRISPR–Cas adaptive immunity
por: Nuñez, James K., et al.
Publicado: (2015)

Potent CRISPR-Cas9 inhibitors from Staphylococcus genomes
por: Watters, Kyle E., et al.
Publicado: (2020)

A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9
por: Dagdas, Yavuz S., et al.
Publicado: (2017)

CRISPR-Cas9 bends and twists DNA to read its sequence
por: Cofsky, Joshua C., et al.
Publicado: (2022)

RNA and DNA Targeting by a Reconstituted Thermus thermophilus Type III-A CRISPR-Cas System
por: Liu, Tina Y., et al.
Publicado: (2017)

Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells
por: Tsuchida, Connor A., et al.
Publicado: (2023)

Decorating chromatin for enhanced genome editing using CRISPR-Cas9
por: Chen, Evelyn, et al.
Publicado: (2022)

Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells
por: Tsuchida, Connor A., et al.
Publicado: (2023)

Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
por: Lin, Steven, et al.
Publicado: (2014)

Correction: RNA and DNA Targeting by a Reconstituted Thermus thermophilus Type III-A CRISPR-Cas System
por: Liu, Tina Y., et al.
Publicado: (2017)

Target preference of Type III-A CRISPR-Cas complexes at the transcription bubble
por: Liu, Tina Y., et al.
Publicado: (2019)

New CRISPR-Cas systems from uncultivated microbes
por: Burstein, David, et al.
Publicado: (2016)

Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch
por: Oakes, Benjamin L, et al.
Publicado: (2016)

Broad-spectrum enzymatic inhibition of CRISPR-Cas12a
por: Knott, Gavin J., et al.
Publicado: (2019)

CRISPR-RNAa: targeted activation of translation using dCas13 fusions to translation initiation factors
por: Otoupal, Peter B, et al.
Publicado: (2022)

Improved genome editing by an engineered CRISPR-Cas12a
por: Ma, Enbo, et al.
Publicado: (2022)

Disabling Cas9 by an anti-CRISPR DNA mimic
por: Shin, Jiyung, et al.
Publicado: (2017)

Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2
por: Thavalingam, Annoj, et al.
Publicado: (2019)

CRISPR-Cas12a exploits R-loop asymmetry to form double-strand breaks
por: Cofsky, Joshua C, et al.
Publicado: (2020)

A CRISPR-Cas9–integrase complex generates precise DNA fragments for genome integration
por: Jakhanwal, Shrutee, et al.
Publicado: (2021)

Deciphering Off-Target Effects in CRISPR-Cas9 through Accelerated Molecular Dynamics
por: Ricci, Clarisse G., et al.
Publicado: (2019)

Enhanced proofreading governs CRISPR-Cas9 targeting accuracy
por: Chen, Janice S., et al.
Publicado: (2017)

Development of an in vivo cleavable donor plasmid for targeted transgene integration by CRISPR-Cas9 and CRISPR-Cas12a
por: Ishibashi, Riki, et al.
Publicado: (2022)

Candidate Phyla Radiation Roizmanbacteria From Hot Springs Have Novel and Unexpectedly Abundant CRISPR-Cas Systems
por: Chen, Lin-Xing, et al.
Publicado: (2019)

The responsiveness of goal attainment scaling using just one goal in controlled clinical trials: an exploratory analysis
por: McGarrigle, Lisa, et al.
Publicado: (2020)

Promotion of Physical Activity in Older People Using mHealth and eHealth Technologies: Rapid Review of Reviews
por: McGarrigle, Lisa, et al.
Publicado: (2020)

CRISPR-Cas9 enables conditional mutagenesis of challenging loci
por: Schick, Joel A., et al.
Publicado: (2016)

Programmable CRISPR‐Cas transcriptional activation in bacteria
por: Ho, Hsing‐I, et al.
Publicado: (2020)

Precise transcript targeting by CRISPR-Csm complexes
por: Colognori, David, et al.
Publicado: (2023)

Kinetic analysis of Cas12a and Cas13a RNA-Guided nucleases for development of improved CRISPR-Based diagnostics
por: Nalefski, Eric A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_28ik06rh97rsq9ctcdo201vblm